Cargando…
Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis
BACKGROUND: Efficacy of tumor necrosis factor alpha (TNF-α) blockers for treatment of ulcerative colitis that is unresponsive to conventional therapy is unclear due to recent studies yielding conflicting results. AIM: To assess the efficacy and safety of anti-TNF-α agents for treatment of ulcerative...
Autores principales: | Lv, Ruxi, Qiao, Weiguang, Wu, Zhiyong, Wang, Yinjun, Dai, Shixue, Liu, Qiang, Zheng, Xuebao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903567/ https://www.ncbi.nlm.nih.gov/pubmed/24475168 http://dx.doi.org/10.1371/journal.pone.0086692 |
Ejemplares similares
-
Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients
por: Kitayama, Moto, et al.
Publicado: (2020) -
Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis
por: Minagawa, Yuki, et al.
Publicado: (2022) -
Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis
por: Uchino, Motoi, et al.
Publicado: (2018) -
Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist
por: Hayashida, Sho, et al.
Publicado: (2020) -
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)